Sort
48,018 grants matching “immunotherapy”
Protein arginine methylation in breast cancer
$382,090Wei Xu · University Of Wisconsin-Madison · R01 · FY2025 · CA
Protein arginine methylation in breast cancer
$382,090Wei Xu · University Of Wisconsin-Madison · R01 · FY2024 · CA
Gene-Editing of Human Pluripotent Stem Cell-Derived Cardiovascular Therapy Grafts to Improve Transplant Outcomes
$382,090Matthew E Brown · University Of Wisconsin-Madison · R56 · FY2022 · HL
Understanding Immunopathogenesis of Hepatitis B Virus
$382,083Jody L Baron · University Of California, San Francisco · R01 · FY2006 · AI
Inducing NK cells to remember and fight cancer
$382,057Jeffrey S Miller · University Of Minnesota · R01 · FY2018 · HL
Inducing NK cells to remember and fight cancer
$382,057Jeffrey S Miller · University Of Minnesota · R01 · FY2017 · HL
Conditional Regulation of T Cell Survival in Immunotherapy
$382,055University Of Washington · U01 · FY2005 · HL
Targeting the colchicine binding site in tubulin for cancer therapy
$382,020Wei Li · University Of Tennessee Health Sci Ctr · R01 · FY2022 · CA
Formulation to Generate Tolerance Towards Type 1 Diabetes
$382,018Kristy M Ainslie · Univ Of North Carolina Chapel Hill · R01 · FY2021 · DK
Use of focused ultrasound to increase melanoma immunogenicity and inhibit tumor-induced T cell tolerance
$382,013Fernando Macian · Albert Einstein College Of Medicine · R01 · FY2020 · CA
Use of focused ultrasound to increase melanoma immunogenicity and inhibit tumor-induced T cell tolerance
$382,013Fernando Macian · Albert Einstein College Of Medicine · R01 · FY2021 · CA
Mismatch Repair and Carcinogenesis
$381,992Richard Fishel · Ohio State University · R01 · FY2023 · CA
Innate Immune Therapy for B-Cell Malignancies
$381,967John C Byrd · Ohio State University · P01 · FY2015 · CA
Innate Immune Therapy for B-Cell Malignancies
$381,967John C Byrd · Ohio State University · P01 · FY2016 · CA
Mechanistic difference of NF-kappaB in lung physiology and tumorigenesis
$381,967Gutian Xiao · University Of Southern California · R01 · FY2023 · CA
Understanding the Behavior of Novel IL13Ralpha2-directed T cell Engager for GBM
$381,961Irina V Balyasnikova · Northwestern University At Chicago · R01 · FY2024 · NS
Nucleic acid modulators and theranostics for ADAR
$381,938Guizhi Zhu · University Of Michigan At Ann Arbor · R35 · FY2023 · GM
Nucleic acid modulators and theranostics for ADAR
$381,938Guizhi Zhu · University Of Michigan At Ann Arbor · R35 · FY2024 · GM
Nucleic acid modulators and theranostics for ADAR
$381,938Guizhi Zhu · University Of Michigan At Ann Arbor · R35 · FY2025 · GM
Fatty acid metabolism regulates ferroptosis in mutant KRAS lung cancer
$381,935Pier P Scaglioni · University Of Cincinnati · R01 · FY2024 · CA
Multi-color Mapping of Cancer Molecular Signatures and Tumor microenvironment
$381,907Jenny J Yang · Georgia State University · R33 · FY2020 · CA
Mechanisms of Arginine Deprivation in Small Cell Lung Cancer
$381,906Trudy Gale Oliver · Duke University · R01 · FY2023 · CA
Mechanisms of Arginine Deprivation in Small Cell Lung Cancer
$381,905Trudy Gale Oliver · Duke University · R01 · FY2022 · CA
Regulatory mechanisms of miR-19b, a novel mediator of T cell autoimmunity
$381,902Qijing Li · Duke University · R01 · FY2014 · AI
Project 1: Siglec15 as a new target for lung cancer immunotherapy
$381,856Lieping Chen · Yale University · P50 · FY2020 · CA